CARA THERAPEUTICS INC's ticker is CARA and the CUSIP is 140755109. A total of 119 filers reported holding CARA THERAPEUTICS INC in Q1 2017. The put-call ratio across all filers is 1.29 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $8,043,000 | +105.0% | 440,000 | +120.0% | 2.91% | +167.5% |
| Q1 2019 | $3,924,000 | +26.1% | 200,000 | +53.8% | 1.09% | +37.2% |
| Q3 2018 | $3,113,000 | -56.0% | 130,000 | -66.2% | 0.79% | -77.5% |
| Q1 2017 | $7,080,000 | +60.4% | 385,000 | -18.9% | 3.52% | +35.5% |
| Q4 2016 | $4,413,000 | -21.7% | 475,000 | -29.6% | 2.60% | -11.9% |
| Q3 2016 | $5,636,000 | +40.3% | 675,000 | -19.2% | 2.95% | +10.0% |
| Q2 2016 | $4,016,000 | -24.5% | 835,000 | -2.3% | 2.68% | -19.1% |
| Q1 2016 | $5,318,000 | -26.1% | 855,000 | +100.2% | 3.32% | +10.2% |
| Q4 2015 | $7,199,000 | +21.4% | 427,000 | +2.9% | 3.01% | +3.2% |
| Q3 2015 | $5,930,000 | +43.5% | 415,000 | +22.1% | 2.92% | +77.5% |
| Q2 2015 | $4,131,000 | +30.5% | 340,000 | +7.9% | 1.64% | +11.8% |
| Q1 2015 | $3,166,000 | +296.7% | 315,000 | +293.8% | 1.47% | +264.8% |
| Q4 2014 | $798,000 | – | 80,000 | – | 0.40% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ridgeback Capital Investments L.P. | 622,140 | $10,489,000 | 45.13% |
| RHO CAPITAL PARTNERS INC | 2,668,057 | $44,983,000 | 15.47% |
| Opaleye Management Inc. | 427,000 | $7,199,000 | 3.01% |
| DAFNA Capital Management LLC | 169,331 | $2,855,000 | 2.54% |
| Private Capital Advisors, Inc. | 246,850 | $4,162,000 | 1.80% |
| WALL STREET ASSOCIATES | 192,300 | $3,242,000 | 0.91% |
| SECTORAL ASSET MANAGEMENT INC | 1,212,578 | $20,444,000 | 0.87% |
| Virtus ETF Advisers LLC | 17,299 | $292,000 | 0.80% |
| CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD | 618,140 | $10,422,000 | 0.58% |
| SPHERA FUNDS MANAGEMENT LTD. | 197,820 | $3,335,000 | 0.49% |